| 1 |
35201948 | Susceptibility to autophagy inhibition is enhanced by dual IGF1R and MAPK/ERK inhibition in pancreatic cancer. | 2022 Feb 24 |
1 |
| 2 |
30833752 | Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. | 2019 Apr |
3 |
| 3 |
31076568 | Phosphorylation of 14-3-3ζ links YAP transcriptional activation to hypoxic glycolysis for tumorigenesis. | 2019 May 10 |
1 |
| 4 |
30041673 | Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer. | 2018 Jul 24 |
1 |
| 5 |
28574828 | Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancer. | 2017 Jul 4 |
1 |
| 6 |
26219899 | CCR7 regulates Twist to induce the epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma. | 2016 Jan |
1 |
| 7 |
23497499 | Enhancing sorafenib-mediated sensitization to gemcitabine in experimental pancreatic cancer through EMAP II. | 2013 Mar 6 |
1 |
| 8 |
19433314 | Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling. | 2009 Aug-Sep |
1 |